BofA on GoodRx Holdings Inc. (GDRX): 'We don’t have a strong view at this time on the potential upside/downside from TrumpRx'

October 9, 2025 2:56 PM EDT Send to a Friend
BofA Securities analyst Michael Cherny reiterated an Underperform rating and $3.40 price target on GoodRx Holdings Inc. (NASDAQ: GDRX).The analyst ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login